Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2012

Open Access 01-06-2012

Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan

Authors: R. Blaauwbroek, H. A. Barf, K. H. Groenier, L. C. Kremer, K. van der Meer, W. J. E. Tissing, A. Postma

Published in: Journal of Cancer Survivorship | Issue 2/2012

Login to get access

Abstract

Purpose

To facilitate family doctor-driven follow-up for adult childhood cancer survivors, we developed a survivor care plan (SCP) for adult survivors and their family doctors.

Methods

The SCP was accessible for survivors and their family doctors on a secure website and as a printed booklet. It included data on diagnosis, treatment and potential risks as well as recommendations for follow-up. Childhood cancer survivors who were off-treatment ≥5 years, aged ≥18 years and not involved in a long-term follow-up program were eligible. They were advised to visit their family doctor. The endpoints were numbers of participants, adherence of family doctors to the guidelines and satisfaction ratings.

Results

The eligibility criteria were fulfilled by 108 survivors. Three family doctors and 15 survivors refused, 10 survivors were non-responders. Of the remaining 80 survivors, 73 survivors visited 72 family doctors. Sixty-nine (96%) family doctors returned data of whom 60 (83%) fully adhered to the recommended tests. The majority of survivors and family doctors were satisfied about the SCP.

Conclusions

A (web-based) SCP for survivors and family doctors can serve as an effective communication vehicle to provide adequate shared care by the long-term follow-up clinic and family doctors.
Literature
1.
go back to reference Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;12:1572–82.CrossRef Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;12:1572–82.CrossRef
2.
go back to reference Blaauwbroek R, Groenier KH, Kamps WA, et al. Late effects in adult survivors of childhood cancer: the need for life-long follow-up. Ann Oncol. 2007;18:1898–902.PubMedCrossRef Blaauwbroek R, Groenier KH, Kamps WA, et al. Late effects in adult survivors of childhood cancer: the need for life-long follow-up. Ann Oncol. 2007;18:1898–902.PubMedCrossRef
3.
go back to reference Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;27:2705–15.CrossRef Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;27:2705–15.CrossRef
4.
go back to reference Goldsby RE, Ablin AR. Surviving childhood cancer; now what? Controversies regarding long-term follow-up. Pediatr Blood Cancer. 2004;43:211–4.PubMedCrossRef Goldsby RE, Ablin AR. Surviving childhood cancer; now what? Controversies regarding long-term follow-up. Pediatr Blood Cancer. 2004;43:211–4.PubMedCrossRef
5.
go back to reference Friedman DL, Freyer DR, Levitt GA. Models of care for survivors of childhood cancer. Pediatr Blood Cancer. 2006;46:159–68.PubMedCrossRef Friedman DL, Freyer DR, Levitt GA. Models of care for survivors of childhood cancer. Pediatr Blood Cancer. 2006;46:159–68.PubMedCrossRef
6.
go back to reference Wallace WH, Blacklay A, Eiser C, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ. 2001;4:271–4.CrossRef Wallace WH, Blacklay A, Eiser C, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ. 2001;4:271–4.CrossRef
7.
go back to reference Oeffinger KC, Mertens AC, Hudson MM, et al. Health care of young adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Fam Med. 2004;2:61–70.PubMedCrossRef Oeffinger KC, Mertens AC, Hudson MM, et al. Health care of young adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Fam Med. 2004;2:61–70.PubMedCrossRef
8.
go back to reference Grunfeld E, Mant D, Yudkin P, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ. 1996;14:665–9.CrossRef Grunfeld E, Mant D, Yudkin P, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ. 1996;14:665–9.CrossRef
9.
go back to reference Agboola OO, Grunfeld E, Coyle D, Perry GA. Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ. 1997;1:879–86. Agboola OO, Grunfeld E, Coyle D, Perry GA. Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ. 1997;1:879–86.
10.
go back to reference Dancey A, Rayatt S, Courthold J, Roberts J. Views of UK melanoma patients on routine follow-up care. Br J Plast Surg. 2005;58:245–50.PubMedCrossRef Dancey A, Rayatt S, Courthold J, Roberts J. Views of UK melanoma patients on routine follow-up care. Br J Plast Surg. 2005;58:245–50.PubMedCrossRef
11.
go back to reference Blaauwbroek R, Tuinier W, Meyboom-de JB, et al. Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study. Lancet Oncol. 2008;9:232–8.PubMedCrossRef Blaauwbroek R, Tuinier W, Meyboom-de JB, et al. Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study. Lancet Oncol. 2008;9:232–8.PubMedCrossRef
12.
go back to reference Burg MA, Lopez ED, Dailey A, et al. The potential of survivorship care plans in primary care follow-up of minority breast cancer patients. J Gen Intern Med. 2009;24 Suppl 2:S467–71.PubMedCrossRef Burg MA, Lopez ED, Dailey A, et al. The potential of survivorship care plans in primary care follow-up of minority breast cancer patients. J Gen Intern Med. 2009;24 Suppl 2:S467–71.PubMedCrossRef
13.
go back to reference Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;1:2270–3.CrossRef Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007;1:2270–3.CrossRef
14.
go back to reference Houlihan NG. Transitioning to cancer survivorship: plans of care. Oncology (Williston Park). 2009;23 Suppl 8:42–8. Houlihan NG. Transitioning to cancer survivorship: plans of care. Oncology (Williston Park). 2009;23 Suppl 8:42–8.
15.
go back to reference Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;10:5112–6.CrossRef Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;10:5112–6.CrossRef
16.
go back to reference Miller R. Implementing a survivorship care plan for patients with breast cancer. Clin J Oncol Nursing. 2008;12:479–87.CrossRef Miller R. Implementing a survivorship care plan for patients with breast cancer. Clin J Oncol Nursing. 2008;12:479–87.CrossRef
17.
go back to reference Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs. 2008;24:208–17.PubMedCrossRef Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs. 2008;24:208–17.PubMedCrossRef
18.
go back to reference van de Poll-Franse LV, van Eenbergen MC. Internet use by cancer survivors: current use and future wishes. Support Care Cancer. 2008;16:1189–95.PubMedCrossRef van de Poll-Franse LV, van Eenbergen MC. Internet use by cancer survivors: current use and future wishes. Support Care Cancer. 2008;16:1189–95.PubMedCrossRef
19.
go back to reference Oeffinger KC, Hudson MM, Mertens AC. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma a mailed, one-page survivorship care plan. Pediatr Blood Cancer. 2010;56:818–24.PubMedCrossRef Oeffinger KC, Hudson MM, Mertens AC. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma a mailed, one-page survivorship care plan. Pediatr Blood Cancer. 2010;56:818–24.PubMedCrossRef
20.
go back to reference Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176–81.PubMedCrossRef Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176–81.PubMedCrossRef
21.
go back to reference Gilbert SM, Miller DC, Hollenbeck BK, et al. Cancer survivorship: challenges and changing paradigms. J Urol. 2008;179:431–8.PubMedCrossRef Gilbert SM, Miller DC, Hollenbeck BK, et al. Cancer survivorship: challenges and changing paradigms. J Urol. 2008;179:431–8.PubMedCrossRef
22.
go back to reference Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2006.
23.
go back to reference Knijnenburg SL, Kremer LC, van den Bos C, et al. Health information needs of childhood cancer survivors and their family. Pediatr Blood Cancer. 2010;54:123–7.PubMedCrossRef Knijnenburg SL, Kremer LC, van den Bos C, et al. Health information needs of childhood cancer survivors and their family. Pediatr Blood Cancer. 2010;54:123–7.PubMedCrossRef
24.
go back to reference Hill-Kayser CE, Vachani C, Hampshire MK, et al. An internet tool for creation of cancer survivorship care plans for survivors and health care providers: design, implementation, use and user satisfaction. J Med Internet Res. 2009;11(3):e39.PubMedCrossRef Hill-Kayser CE, Vachani C, Hampshire MK, et al. An internet tool for creation of cancer survivorship care plans for survivors and health care providers: design, implementation, use and user satisfaction. J Med Internet Res. 2009;11(3):e39.PubMedCrossRef
25.
go back to reference Bashore L. Childhood and adolescent cancer survivors' knowledge of their disease and effects of treatment. J Pediatr Oncol Nurs. 2004;21:98–102.PubMedCrossRef Bashore L. Childhood and adolescent cancer survivors' knowledge of their disease and effects of treatment. J Pediatr Oncol Nurs. 2004;21:98–102.PubMedCrossRef
26.
go back to reference Kadan-Lottick NS, Robison LL, Gurney JG, et al. Childhood cancer survivors' knowledge about their past diagnosis and treatment: childhood cancer survivor study. JAMA. 2002;10:1832–9.CrossRef Kadan-Lottick NS, Robison LL, Gurney JG, et al. Childhood cancer survivors' knowledge about their past diagnosis and treatment: childhood cancer survivor study. JAMA. 2002;10:1832–9.CrossRef
27.
go back to reference Pennery E, Mallet J. A preliminary study of patients' perceptions of routine follow-up after treatment for breast cancer. Eur J Oncol Nurs. 2000;4:138–45.PubMedCrossRef Pennery E, Mallet J. A preliminary study of patients' perceptions of routine follow-up after treatment for breast cancer. Eur J Oncol Nurs. 2000;4:138–45.PubMedCrossRef
Metadata
Title
Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan
Authors
R. Blaauwbroek
H. A. Barf
K. H. Groenier
L. C. Kremer
K. van der Meer
W. J. E. Tissing
A. Postma
Publication date
01-06-2012
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2012
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-011-0207-5

Other articles of this Issue 2/2012

Journal of Cancer Survivorship 2/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine